Issue Contents:  Sep 28, 2009

• Allos' Folotyn Wins Accelerated PTCL Nod; More Trials to Come
• Auxilium Raising $107M on heels of Xiaflex Panel Win
• Incyte Raising $540M to redo debt and aid partnering efforts
• Senate Panel Rejects $106B in Rebates from Drugmakers
• NicOx Submits Naproxcinod's NDA; Celebrex in Crosshairs
• Other News to Note
• Clinic Roundup
• Appointments and Advancements

      The above issue is also available as one PDF File